| Term Name: | beta-D-GalNAc-(1->4)-[alpha-Neu5Ac-(2->3)]-beta-D-Gal-(1->4)-beta-D-GalNAc-(1->3)-beta-D-Gal-(1->4)-beta-D-Glc-(1<->1')-Cer |
|---|---|
| Synonyms: | (2S,3R,4E)-2-alkanamido-3-hydroxyoctadec-4-en-1-yl 2-acetamido-2-deoxy-beta-D-galactopyranosyl-(1->4)-[5-acetamido-3,5-dideoxy-D-glycero-alpha-D-galacto-non-2-ulopyranonosyl-(2->3)]-beta-D-galactopyranosyl-(1->4)-2-acetamido-2-deoxy-beta-D-galactopyranosy, (Gal)2 (GalNAc)2 (Glc)1 (Neu5Ac)1 (Cer)1, beta-D-GalpNAc-(1->4)-[alpha-Neup5Ac-(2->3)]-beta-D-Galp-(1->4)-beta-D-GalpNAc-(1->3)-beta-D-Galp-(1->4)-beta-D-Glcp-(1<->1')-Cer, IV3NeuAc-nLc4-Cer, IV4GalNAcb, SPG(alpha2-3)-GalNAc |
| Definition: | A sialopentaosylceramide having β-D-GalNAc-(1→4)-[α-Neu5Ac-(2→3)]-β-D-Gal-(1→4)-β-D-GalNAc-(1→3)-β-D-Gal-(1→4)-β-D-Glc as the sialopentaosyl component. |
| Ontology: | ChEBI [CHEBI:66972] ( EBI ) |